Zykadia Cap

Discontinuation of Zykadia 150mg Hard Capsules

Zofran injection

Discontinuation of Zofran 8ml & 4ml Injection

Rate this content: 
No votes yet
August 2023 | IE298137

Ask Speakers


Medical Information Request

Reporting of side effects
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk profile of the medicinal product. All suspected adverse reactions should be reported to HPRA Pharmacovigilance, website www.hpra.ie. Adverse events can also be reported to Novartis preferably at www.novartis.com/report, by emailing [email protected] or by calling (01) 2080 612.